Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/10/2026 | Q4 | $3.9B | -- | -- | $2.37 | -- |
| 10/27/2025 | Q3 | $4.4B | $5B | $3.56 | $2.25 | $1.31 |
| 07/29/2025 | Q2 | $4.3B | $5.1B | $3.23 | $2.30 | $0.93 |
| 04/29/2025 | Q1 | $4.8B | $4.6B | $1.48 | $1.31 | $0.16 |
| 02/10/2025 | Q4 | $3.9B | $4.4B | $2.42 | $1.80 | $0.61 |
| 10/30/2024 | Q3 | $3.8B | $4.6B | $2.56 | $1.95 | $0.61 |
| 07/30/2024 | Q2 | $3.9B | $4.1B | $3.30 | $2.21 | $1.09 |
| 04/29/2024 | Q1 | $3.9B | $3.9B | $2.92 | $2.09 | $0.83 |
| 02/14/2024 | Q4 | $3.3B | $3.8B | $6.12 | $2.01 | $4.11 |
| 10/30/2023 | Q3 | -- | -- | $1.88 | $1.57 | $0.31 |
| 07/26/2023 | Q2 | -- | -- | $1.75 | $1.59 | $0.16 |
| 04/26/2023 | Q1 | -- | -- | $1.87 | $1.45 | $0.42 |
| 02/13/2023 | Q4 | -- | -- | $2.26 | $1.34 | $0.92 |
| 10/26/2022 | Q3 | -- | -- | $0.02 | $0.18 | -$0.16 |
| 07/27/2022 | Q2 | -- | -- | $1.04 | $1.07 | -$0.03 |
| 04/27/2022 | Q1 | -- | -- | $0.48 | $1.07 | -$0.59 |
| 02/09/2022 | Q4 | -- | -- | $1.58 | $1.00 | $0.58 |
| 10/27/2021 | Q3 | -- | -- | $0.98 | $0.35 | $0.63 |
| 07/28/2021 | Q2 | -- | -- | $1.63 | $0.84 | $0.79 |
| 04/27/2021 | Q1 | -- | -- | $1.05 | $0.45 | $0.60 |
| 02/09/2021 | Q4 | -- | -- | $1.30 | -- | -- |
| 10/27/2020 | Q3 | -- | -- | $1.00 | -- | -- |
| 07/29/2020 | Q2 | -- | -- | $0.71 | -- | -- |
| 05/04/2020 | Q1 | -- | -- | $0.32 | -- | -- |
| 02/11/2020 | Q4 | -- | -- | $0.76 | -- | -- |
| 10/29/2019 | Q3 | -- | -- | $0.92 | -- | -- |
| 07/29/2019 | Q2 | -- | -- | $1.12 | -- | -- |
| 04/30/2019 | Q1 | -- | -- | $1.07 | -- | -- |
| 02/12/2019 | Q4 | -- | -- | $0.31 | -- | -- |
| 10/30/2018 | Q3 | -- | -- | $0.53 | -- | -- |
| 07/31/2018 | Q2 | -- | -- | $0.56 | -- | -- |
| 05/01/2018 | Q1 | -- | -- | $0.33 | -- | -- |
| 02/12/2018 | Q4 | -- | -- | $0.49 | -- | -- |
| 10/26/2017 | Q3 | -- | -- | -$0.13 | -- | -- |
| 07/26/2017 | Q2 | -- | -- | $0.42 | -- | -- |
| 04/25/2017 | Q1 | -- | -- | $0.58 | -- | -- |
| 02/13/2017 | Q4 | -- | -- | $0.17 | -- | -- |
| 10/27/2016 | Q3 | -- | -- | $0.66 | -- | -- |
| 07/27/2016 | Q2 | -- | -- | $0.55 | -- | -- |
| 04/27/2016 | Q1 | -- | -- | $0.40 | -- | -- |
| 02/10/2016 | Q4 | -- | -- | $0.14 | -- | -- |
Arch Capital Group Ltd. reported $5B worth of top line sales in its most recent quarter.
Arch Capital Group Ltd. announced earnings per share of $3.56 which represents a beat of analyst forecast a $2.25 per share.
Arch Capital Group Ltd. reported -- that represents -- per share over the last quarter.
Arch Capital Group Ltd.'s earnings are forecast to decrease from $11.19 per share to $8.82 per share next year representing a decrease of -17.34%.
Arch Capital Group Ltd.'s next earnings date is February 10, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.